Trial · NCT02157610
Smoking Cessation for Cervical Cancer Survivors
NCT02157610, Not applicable, Completed, H. Lee Moffitt Cancer Center and Research Institute; results first posted 2023-04-12
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Smoking Cessation for Cervical Cancer Survivors. Trials, record NCT02157610. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02157610
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Smoking Cessation for Cervical Cancer Survivors
- NCT number
- NCT02157610
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 202 participants, actual
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Conditions
- Cervical Cancer, Tobacco Use, Smoking Cessation
- Interventions
- Self-Help Materials, Nicotine Patch, REDCap, Saliva Test, Telephone Counseling Sessions, Nicotine lozenge
- First posted
- 2014-06-06
- Last updated
- 2023-07-20
- Results first posted
- 2023-04-12
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants With Smoking Abstinence | 18 months | To test treatment effect at 18 months, logistic regression analysis conducted with abstinence as outcome variable, and treatment (a two-level categorical variable) as predictor, adjusting for covariates, specifically, factors used in the minimization procedures (race/ethnicity, language, age, education, income, cigarettes/day, cervical cancer stage, and time since diagnosis). A logit link and binomial variance function assumed for generalized linear mixed model (GLMM), regression and parameterize them with blocking on individual nested within treatment conditions. Treatment and time included, as well as their interaction, with adjustment for relevant covariates. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants With Smoking Abstinence | 18 months | participants included in analysis | percentage | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Smoking Abstinence | Standard Treatment (ST) | 12.9 | percentage | ||
| Percentage of Participants With Smoking Abstinence | Motivation + Problem Solving (MAPS) | 14.2 | percentage |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard Treatment (ST) | 100 | |
| Overall Study | STARTED | Motivation + Problem Solving (MAPS) | 102 | |
| Overall Study | COMPLETED | Standard Treatment (ST) | 96 | |
| Overall Study | COMPLETED | Motivation + Problem Solving (MAPS) | 98 | |
| Overall Study | NOT COMPLETED | Standard Treatment (ST) | 4 | |
| Overall Study | NOT COMPLETED | Motivation + Problem Solving (MAPS) | 4 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard Treatment (ST) | 4 | 100 |
| Total, all-cause mortality | Motivation + Problem Solving (MAPS) | 4 | 102 |
| Total, other adverse events | Standard Treatment (ST) | 0 | 0 |
| Total, other adverse events | Motivation + Problem Solving (MAPS) | 0 | 0 |
| Total, serious adverse events | Standard Treatment (ST) | 0 | 0 |
| Total, serious adverse events | Motivation + Problem Solving (MAPS) | 0 | 0 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01CA172786 | Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare System | VIDRINE, JENNIFER IRVIN | H. LEE MOFFITT CANCER CTR & RES INST | NATIONAL CANCER INSTITUTE | 2014 to 2019 |
Source NIH RePORTER
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Standard Treatment (ST) vs Motivation + Problem Solving (MAPS): deaths from any cause |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02157610
GET https://conductscience.org/api/trials/v1/NCT02157610/registered